The rate of gestational diabetes among pregnant women in the U.S. has significantly increased in recent years. In this background, a new nationwide study is being carried out in the USA to examine whether medically tailored meals can help address the rise in gestational diabetes mellitus.
The five-year study will be one of the first to pair medically tailored meals with existing home-visiting programs to target GDM.
(Source: Pixabay)
Chicago/USA – The rate of gestational diabetes among pregnant individuals in the U.S. has increased in recent years, raising alarms among health experts as it exacerbates the nation’s maternal mortality crisis. This increase, linked to rising obesity rates and limited access to prenatal care in many communities, underscores the urgent need for systemic interventions to protect maternal health.
Northwestern Medicine, Brown University and California Polytechnic State University are part of a new nationwide study to examine whether medically tailored meals can help address the rise in gestational diabetes mellitus (GDM).
The five-year study, funded by a 10 million-dollar award from the Patient-Centered Outcomes Research Institute (PCORI), will be one of the first to pair medically tailored meals with existing home-visiting programs to target GDM. The approach has been shown to improve health outcomes and reduce food insecurity, but little research has examined its use to treat GDM specifically.
“’Food-as-medicine’ approaches are gaining increasing attention, with this project being among the first to rigorously evaluate the impact of medically tailored meals on managing gestational diabetes and preventing diabetes,” said Darius Tandon, professor of medical social sciences at Northwestern University Feinberg School of Medicine, who will co-lead the collaboration in the Midwest and South.
The U.S. ranks lowest among high-income countries for maternal health. GDM, and the subsequent development of Type 2 diabetes, is a major cause of maternal morbidity, especially among under-resourced people. Roughly one-third to almost half of people diagnosed with GDM during pregnancy develop diabetes or pre-diabetes in the year after giving birth.
The condition has also been shown to affect children, as intrauterine exposure to GDM increases the risk of rapid weight gain during infancy and the later development of obesity and diabetes. Researchers believe treating the condition will offer “cross-generational” benefits.
“This research study was selected for PCORI funding for its potential to provide real-world data on the comparative clinical effectiveness of different approaches to improve maternal health outcomes,” said PCORI executive director Dr. Nakela L. Cook. “We look forward to following the study’s progress and working with Northwestern to share its results.”
The study, titled “Healthy Moms/Mamis Saludables: Partnership To Prevent Maternal Diabetes in U.S. Home Visiting Programs,” will work with families already enrolled in home-visiting programs, offering meals formulated specifically for people at risk for GDM. Some participants also will receive additional information on lifestyle changes to help prevent the disease.
Home-visiting programs are currently available in every state and territory, providing services for at least 500,000 women and children in the U.S. “Home visiting is an innovative setting for delivering lifestyle interventions,” said Tandon, who also is the director of the Institute for Public Health and Medicine Center for Community Health at Northwestern. “This project has the potential to be highly impactful if found to be successful given the nationwide reach of home-visiting programs.”
The study was selected through PCORI’s highly competitive review process in which patients, caregivers and other stakeholders join scientists to evaluate proposals. The award has been approved pending completion of PCORI’s business and programmatic review and issuance of a formal award contract.
Date: 08.12.2025
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.
In addition to Tandon, the research team includes Dr. Jenny Jia of Northwestern; Rena Wing and Stephanie Parade of Brown University; and Suzanne Phelan of California Polytechnic State University.
PCORI is an independent, nonprofit organization authorized by Congress with a mission to fund patient-centered comparative clinical effectiveness research that provides patients, their caregivers and clinicians with the evidence-based information they need to make better-informed health and health care decisions.